Scholars@Duke

Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia.

Publication ,  Journal Article
Young, KH
Published in: Leukemia
November 2020
Published version (DOI) Link to item

Duke Scholars

Ken H Young
Author Ken H Young Pathology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Leukemia

DOI

10.1038/s41375-020-0861-6

EISSN

1476-5551

Publication Date

November 2020

Volume

34

Issue

11

Start / End Page

3075 / 3076

Location

England

Related Subject Headings

  • Prognosis
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • Male
  • Immunology
  • Humans
  • Female
  • Disease Susceptibility
  • Disease Management
  • Clinical Decision-Making
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Young, K. H. (2020). Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia. Leukemia, 34(11), 3075–3076. https://doi.org/10.1038/s41375-020-0861-6
Young, Ken H. “Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia.” Leukemia 34, no. 11 (November 2020): 3075–76. https://doi.org/10.1038/s41375-020-0861-6.
Young, Ken H. “Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia.” Leukemia, vol. 34, no. 11, Nov. 2020, pp. 3075–76. Pubmed, doi:10.1038/s41375-020-0861-6.

Published In

Leukemia

DOI

10.1038/s41375-020-0861-6

EISSN

1476-5551

Publication Date

November 2020

Volume

34

Issue

11

Start / End Page

3075 / 3076

Location

England

Related Subject Headings

  • Prognosis
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • Male
  • Immunology
  • Humans
  • Female
  • Disease Susceptibility
  • Disease Management
  • Clinical Decision-Making
  • 3211 Oncology and carcinogenesis